Cyclacel Pharmaceuticals

-$0.11 (-2.21%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCC and other ETFs, options, and stocks.

About CYCC

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases.

CEO
Spiro Rombotis
Employees
—
Headquarters
Berkeley Heights, New Jersey
Founded
1996

CYCC Key Statistics

Market Cap
44.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
65.67K
High Today
$4.97
Low Today
$4.85
Open Price
$4.97
Volume
59.95K
52 Week High
$11.42
52 Week Low
$3.12

CYCC Earnings

-$2.90
-$1.93
-$0.97
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure